Oncopeptides Weighing Pepaxto Withdrawal Request

 
• By Sue Sutter
  
Oncopeptides-FDA tug of war
The tug of war between FDA and Oncopeptides over withdrawal of Pepaxto continues. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock image
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards